• 22/01/2021

    Tajikistan’s tuberculosis patients receive groundbreaking new treatment

    Tajikistan is the first country in Central Asia to provide people with tuberculosis (TB)  access to  the groundbreaking new BPaL…

    Lees meer

  • 21/01/2021

    TB expert Max Meis: “My career is characterized by pandemics”

    After 11 years at KNCV Tuberculosis Foundation, Dutch TB expert Max Meis (66) is closing the virtual office door behind…

    Lees meer

  • 13/01/2021

    How digital technologies can empower patients to succeed in TB treatment

    The run-in phase of the ASCENT project has started, enrolling TB patients on digital adherence technologies in the Philippines…

    Lees meer

  • 15/12/2020

    Fear of TB infection can lead to stigma

    The recent research ‘Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the…

    Lees meer

  • 23/11/2020

    New treatment offers hope for XDR-TB patient Hanna

    Hanna from Ukraine is one of the first TB patients in the world to be treated with a new, groundbreaking…

    Lees meer

  • 23/11/2020

    Ukraine TB patients first to receive groundbreaking new drug regimen

    Ukraine is the first country in the world to provide tuberculosis (TB) patients with the groundbreaking new BPaL treatment in…

    Lees meer

  • 12/11/2020

    Smart medication container included in GDF product catalog

    Stop TB Partnership’s Global Drug Facility (GDF) and the Unitaid-funded Adherence Support Coalition to End TB (ASCENT project) announce the…

    Lees meer

  • 27/10/2020

    Programme: KNCV at the Union World Conference

    Wednesday, 21 Oct 2020   10:00 – 11:00: Person-centred care: the advantages and challenges Online/virtual, E-posters KNCV speakers:…

    Lees meer

  • 27/10/2020

    ASCENT project launches new website

    The Unitaid-funded ASCENT (Adherence Support Coalition to End TB) project has launched its official website: https://www.digitaladherence.org/…

    Lees meer

  • 21/10/2020

    KNCV implementing partner for new LIFT-TB initiative

    KNCV Tuberculosis Foundation is one of the implementing partners of the LIFT-TB initiative of TB Alliance,…

    Lees meer

  • 19/10/2020

    Riziki: “I encourage any TB patient to use 99DOTS if they can”

    The KNCV-led and Stop TB Partnership funded TB REACH project in Tanzania introduced 99DOTS (medication sleeves) as a Digital…

    Lees meer

  • 02/10/2020

    WoW trucks: revolutionary TB and COVID-19 testing in Nigeria

    KNCV Tuberculosis Foundation (KNCV) Nigeria contributes in a revolutionary way to the fight against tuberculosis (TB) and COVID-19. Recently the…

    Lees meer

  • 02/10/2020

    Behind the mask: working on the WoW-truck

    Chimezie Dimkpa, the KNCV Nigeria ACF (Active Case Finding) radiographer onboard the WoW truck shares his experience working with patients…

    Lees meer

  • 28/08/2020

    TREATS will begin testing for COVID-19 in Zambia using TB testing facilities

    The TREATS study will soon begin testing for COVID-19 in the Bwacha – Ngungu community of Kabwe in Zambia,…

    Lees meer

  • 25/08/2020

    Mustapha Gidado new Executive Director of KNCV Tuberculosis Foundation

    Dr. Mustapha Gidado takes up the position of Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek, who…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Ghana
Indonesia
Kazachstan
Kenya
Kyrgyzstan
Malawi
Namibia
Nigeria
Rwanda
South Africa
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centered Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report Summary 2019
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.